Last edition
News about "James Hackworth"
Adneuris Presents New Cebranopadol Data for Acute Pain Treatment
Adneuris presents new cebranopadol data showing lower abuse potential and positive phase 3 ALLEVIATE results for moderate-to-severe acute pain.
James Hackworth | 14/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members